FindTrial
Sign In

SRT

RADIATION6 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Centre Hospitalier Universitaire, Amiens, Institut Cancerologie de l'Ouest, Haaglanden Medical Centre, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions

Adenocarcinoma of the ProstateBiochemical RecurrenceBrain MetastasesHuntington DiseaseLocally Advanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung CancerParkinson DiseaseProstate Cancer

Phase 2

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
CompletedNCT02203695
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsAdenocarcinoma of the Prostate
Start: 2015-03-28End: 2022-12-31Updated: 2025-10-28
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
RecruitingNCT05753566
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolBiochemical Recurrence, Prostate Cancer
Start: 2023-03-31End: 2028-03-31Target: 96Updated: 2023-03-06
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
RecruitingNCT06305832
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolBiochemical Recurrence, Prostate Cancer
Start: 2023-09-07End: 2028-03-31Target: 102Updated: 2024-03-12

Phase 3

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy
NCT05111197
Institut Cancerologie de l'OuestLocally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer
Start: 2022-01-12End: 2025-01-31Target: 112Updated: 2023-02-21

Unknown Phase

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm
CompletedNCT02814201
Centre Hospitalier Universitaire, AmiensHuntington Disease, Parkinson Disease
Start: 2011-07-31End: 2016-11-30Updated: 2016-12-05
Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases
RecruitingNCT05346367
Haaglanden Medical CentreBrain Metastases
Start: 2022-07-18End: 2027-03-31Target: 130Updated: 2024-03-12

Related Papers

Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial.
2024-08-2212 citations
Rezvilutamide in combination with androgen-deprivation therapy, with or without salvage radiotherapy, for patients experiencing biochemical recurrence following radical prostatectomy: A multi-center, open-label, two-cohort study.
Journal of Clinical Oncology2024-01-29
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
BMC Cancer2023-03-2515 citations
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
Journal of Clinical Oncology2022-11-1135 citations
Phase II, double-blind, randomized study of salvage radiation therapy (SRT) plus enzalutamide or placebo for high-risk PSA-recurrent prostate cancer after radical prostatectomy: The SALV-ENZA Trial.
Journal of Clinical Oncology2022-06-014 citations
Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study
Frontiers in Oncology2020-03-126 citations
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
2019-06-135 citations